Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $56
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $52 to $56.
Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $52 to $56.